Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
Oncology advanced practice providers should have comprehensive knowledge and competency in the area of survivorship care. This module explores the considerations and principles of comprehensive survival care of the patient with cancer.
High-risk anti-cancer medications, such as chemotherapy, immunotherapy and targeted therapy require a consistent and standardized approach to handling, ordering, preparing, dispensing, and administering to ensure patient and provider safety.
Get a comprehensive overview of cancer treatment options and oncologic emergencies. Learn nursing interventions to successfully identify and manage disease and treatment-related symptoms. The Treatment and Symptom Management online course offers foundational knowledge for the safe and effective care of the oncology patient. This course is designed for oncology nurses with some experience in oncology.
This module explores the considerations and principles of comprehensive survivorship care of patients with cancer. Learn considerations of each treatment modality, psychosocial and spiritual impacts of treatment, best practice, and the essential influence of the advanced practice provider in care of the cancer survivor.
Review this huddle card to learn how clinical trials impact cancer care and the oncology nurse's role in caring for patients enrolled in clinical trials. This card covers the different phases of a trial and the nursing considerations for those working with patients in a clinical trial.
This program provides a foundational knowledge of the role for those new to the navigation role.
This module, a part of the comprehensive Hematopoietic Stem Cell Transplantation course, provides an overview of graft-versus-host disease (GVHD), a common complication of stem cell transplant.
Cancer care across the healthcare continuum has been revolutionized by advances in the understanding and application of genomics. The paradigm shift to biomarker-driven treatment decisions is a large step toward achieving precision oncology, which is the use of tumor-specific information, like genomic information, to inform cancer care.